{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,11,4]],"date-time":"2026-11-04T13:25:08Z","timestamp":1793798708822,"version":"4.6.1"},"reference-count":62,"publisher":"Springer Science and Business Media LLC","issue":"1","license":[{"start":{"date-parts":[[2023,1,28]],"date-time":"2023-01-28T00:00:00Z","timestamp":1674864000000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by\/4.0"},{"start":{"date-parts":[[2023,1,28]],"date-time":"2023-01-28T00:00:00Z","timestamp":1674864000000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by\/4.0"}],"funder":[{"DOI":"10.13039\/100007787","name":"National Research Centre","doi-asserted-by":"publisher","award":["TT110801"],"award-info":[{"award-number":["TT110801"]}],"id":[{"id":"10.13039\/100007787","id-type":"DOI","asserted-by":"publisher"}]},{"name":"National Research Centre Egypt"}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["Sci Rep"],"abstract":"<jats:title>Abstract<\/jats:title>\n                  <jats:p>\n                    The persistent evolution of drug-resistant influenza strains represents a global concern. The innovation of new treatment approaches through drug screening strategies and investigating the antiviral potential of bioactive natural-based chemicals may address the issue. Herein, we screened the anti-influenza efficacy of some biologically active indole and \u03b2-carboline (\u03b2C) indole alkaloids against two different influenza A viruses (IAV) with varied host range ranges; seasonal influenza A\/Egypt\/NRC098\/2019(H1N1) and avian influenza A\/chicken\/Egypt\/N12640A\/2016(H5N1). All compounds were first assessed for their half-maximal cytotoxic concentration (CC\n                    <jats:sub>50<\/jats:sub>\n                    ) in MDCK cells and half-maximal inhibitory concentrations (IC\n                    <jats:sub>50<\/jats:sub>\n                    ) against influenza A\/H5N1. Intriguingly, Strychnine sulfate, Harmalol, Harmane, and Harmaline showed robust anti-H5N1 activities with IC\n                    <jats:sub>50<\/jats:sub>\n                    values of 11.85, 0.02, 0.023, and 3.42\u00a0\u00b5g\/ml, respectively, as compared to zanamivir and amantadine as control drugs (IC\n                    <jats:sub>50<\/jats:sub>\n                    \u2009=\u20090.079\u00a0\u00b5g\/ml and 17.59\u00a0\u00b5g\/ml, respectively). The efficacy of the predefined phytochemicals was further confirmed against influenza A\/H1N1 and they displayed potent anti-H1N1 activities compared to reference drugs. Based on SI values, the highly promising compounds were then evaluated for antiviral efficacy through plaque reduction assay and consistently they revealed high viral inhibition percentages at non-toxic concentrations. By studying the modes of antiviral action, Harmane and Harmalol could suppress viral infection via interfering mainly with the viral replication of the influenza A\/H5N1 virus, whilst Harmaline exhibited a viricidal effect against the influenza A\/H5N1 virus. Whereas, Strychnine sulfate elucidated its anti-influenza potency by interfering with viral adsorption into MDCK cells. Consistently, chemoinformatic studies showed that all studied phytochemicals illustrated HB formations with essential peptide cleft through the NH of indole moiety. Among active alkaloids, harmalol displayed the best lipophilicity metrics including ligand efficiency (LE) and ligand lipophilic efficiency (LLE) for both viruses. Compounds geometry and their ability to participate in HB formation are very crucial.\n                  <\/jats:p>","DOI":"10.1038\/s41598-023-27954-0","type":"journal-article","created":{"date-parts":[[2023,1,28]],"date-time":"2023-01-28T06:09:06Z","timestamp":1674886146000},"update-policy":"https:\/\/doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":71,"title":["Antiviral activities of plant-derived indole and \u03b2-carboline alkaloids against human and avian influenza viruses"],"prefix":"10.1038","volume":"13","author":[{"given":"Akram","family":"Hegazy","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Sara H.","family":"Mahmoud","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Yaseen A. M. M.","family":"Elshaier","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Noura M. Abo","family":"Shama","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Nasr Fawzy","family":"Nasr","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"M. A.","family":"Ali","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Assem Mohamed","family":"El-Shazly","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Islam","family":"Mostafa","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Ahmed","family":"Mostafa","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"297","published-online":{"date-parts":[[2023,1,28]]},"reference":[{"key":"27954_CR1","doi-asserted-by":"publisher","first-page":"497","DOI":"10.3390\/v10090497","volume":"10","author":"A Mostafa","year":"2018","unstructured":"Mostafa, A., Abdelwhab, E. M., Mettenleiter, T. C. & Pleschka, S. Zoonotic potential of influenza A viruses: A comprehensive overview. Viruses 10, 497. https:\/\/doi.org\/10.3390\/v10090497 (2018).","journal-title":"Viruses"},{"key":"27954_CR2","doi-asserted-by":"publisher","first-page":"343","DOI":"10.3389\/fcimb.2018.00343","volume":"8","author":"KR Short","year":"2018","unstructured":"Short, K. R., Kedzierska, K. & Van de Sandt, C. E. Back to the future: Lessons learned from the 1918 influenza pandemic. Front. Cell. Infect. Microbiol. 8, 343 (2018).","journal-title":"Front. Cell. Infect. Microbiol."},{"key":"27954_CR3","doi-asserted-by":"publisher","first-page":"9","DOI":"10.3201\/eid1201.051254","volume":"12","author":"ED Kilbourne","year":"2006","unstructured":"Kilbourne, E. D. Influenza pandemics of the 20th century. Emerg. Infect. Dis. 12, 9 (2006).","journal-title":"Emerg. Infect. Dis."},{"key":"27954_CR4","doi-asserted-by":"crossref","first-page":"951","DOI":"10.1093\/cid\/ciz722","volume":"70","author":"AS Monto","year":"2020","unstructured":"Monto, A. S. & Fukuda, K. Lessons from influenza pandemics of the last 100 years. Clin. Infect. Dis. 70, 951\u2013957 (2020).","journal-title":"Clin. Infect. Dis."},{"key":"27954_CR5","doi-asserted-by":"publisher","first-page":"1385","DOI":"10.2147\/DDDT.S299120","volume":"15","author":"H Ti","year":"2021","unstructured":"Ti, H., Zhuang, Z., Yu, Q. & Wang, S. Progress of plant medicine derived extracts and alkaloids on modulating viral infections and inflammation. Drug Des. Dev. Ther. 15, 1385 (2021).","journal-title":"Drug Des. Dev. Ther."},{"key":"27954_CR6","doi-asserted-by":"publisher","first-page":"903","DOI":"10.3390\/molecules27030903","volume":"27","author":"FL Abookleesh","year":"2022","unstructured":"Abookleesh, F. L., Al-Anzi, B. S. & Ullah, A. Potential antiviral action of alkaloids. Molecules 27, 903 (2022).","journal-title":"Molecules"},{"key":"27954_CR7","doi-asserted-by":"publisher","first-page":"292","DOI":"10.3389\/fphar.2016.00292","volume":"7","author":"Q-U- Ain","year":"2016","unstructured":"Ain, Q.-U.-, Khan, H., Mubarak, M. S. & Pervaiz, A. Plant alkaloids as antiplatelet agent: Drugs of the future in the light of recent developments. Front. Pharmacol. 7, 292 (2016).","journal-title":"Front. Pharmacol."},{"key":"27954_CR8","doi-asserted-by":"publisher","first-page":"505","DOI":"10.1016\/B978-0-12-816455-6.00015-9","volume":"2020","author":"P Dey","year":"2020","unstructured":"Dey, P. et al. Analysis of alkaloids (indole alkaloids, isoquinoline alkaloids, tropane alkaloids). Recent Adv. Nat. Prod. Anal. 2020, 505\u201367. https:\/\/doi.org\/10.1016\/B978-0-12-816455-6.00015-9 (2020).","journal-title":"Recent Adv. Nat. Prod. Anal."},{"key":"27954_CR9","doi-asserted-by":"publisher","first-page":"206","DOI":"10.1073\/pnas.1617020114","volume":"114","author":"RU Kadam","year":"2017","unstructured":"Kadam, R. U. & Wilson, I. A. Structural basis of influenza virus fusion inhibition by the antiviral drug Arbidol. Proc. Natl. Acad. Sci. 114, 206\u2013214 (2017).","journal-title":"Proc. Natl. Acad. Sci."},{"key":"27954_CR10","doi-asserted-by":"publisher","first-page":"4676","DOI":"10.1128\/AAC.00245-12","volume":"56","author":"B Devogelaere","year":"2012","unstructured":"Devogelaere, B. et al. TMC647055, a potent nonnucleoside hepatitis C virus NS5B polymerase inhibitor with cross-genotypic coverage. Antimicrob. Agents Chemother. 56, 4676\u20134684 (2012).","journal-title":"Antimicrob. Agents Chemother."},{"key":"27954_CR11","doi-asserted-by":"publisher","first-page":"9996","DOI":"10.1021\/acs.jmedchem.9b01289","volume":"62","author":"FX Ruiz","year":"2019","unstructured":"Ruiz, F. X., Hoang, A., Das, K. & Arnold, E. Structural basis of HIV-1 inhibition by nucleotide-competing reverse transcriptase inhibitor INDOPY-1. J. Med. Chem. 62, 9996\u201310002. https:\/\/doi.org\/10.1021\/acs.jmedchem.9b01289 (2019).","journal-title":"J. Med. Chem."},{"key":"27954_CR12","doi-asserted-by":"publisher","first-page":"1280","DOI":"10.3390\/plants10071280","volume":"10","author":"LM Monsalve-Escudero","year":"2021","unstructured":"Monsalve-Escudero, L. M. et al. The antiviral and virucidal activities of voacangine and structural analogs extracted from tabernaemontana cymosa depend on the dengue virus strain. Plants 10, 1280 (2021).","journal-title":"Plants"},{"key":"27954_CR13","doi-asserted-by":"publisher","first-page":"1","DOI":"10.1186\/s12906-021-03386-z","volume":"21","author":"LM Monsalve-Escudero","year":"2021","unstructured":"Monsalve-Escudero, L. M. et al. Indole alkaloids inhibit zika and chikungunya virus infection in different cell lines. BMC Complement. Med. Ther. 21, 1\u201317 (2021).","journal-title":"BMC Complement. Med. Ther."},{"key":"27954_CR14","doi-asserted-by":"publisher","first-page":"18","DOI":"10.3390\/biom11010018","volume":"11","author":"A Llanes","year":"2020","unstructured":"Llanes, A., Cruz, H., Nguyen, V. D., Larionov, O. V. & Fernandez, P. L. A. Computational approach to explore the interaction of semisynthetic nitrogenous heterocyclic compounds with the SARS-CoV-2 main protease. Biomolecules 11, 18. https:\/\/doi.org\/10.3390\/biom11010018 (2020).","journal-title":"Biomolecules"},{"key":"27954_CR15","doi-asserted-by":"publisher","first-page":"101890","DOI":"10.1016\/j.bcab.2020.101890","volume":"31","author":"T Khan","year":"2021","unstructured":"Khan, T., Khan, M. A., Mashwani, Z. U., Ullah, N. & Nadhman, A. Therapeutic potential of medicinal plants against COVID-19: The role of antiviral medicinal metabolites. Biocatal. Agric. Biotechnol. 31, 101890. https:\/\/doi.org\/10.1016\/j.bcab.2020.101890 (2021).","journal-title":"Biocatal. Agric. Biotechnol."},{"key":"27954_CR16","doi-asserted-by":"publisher","first-page":"103092","DOI":"10.1016\/j.arabjc.2021.103092","volume":"14","author":"MAA Fayed","year":"2021","unstructured":"Fayed, M. A. A. et al. Structure- and ligand-based in silico studies towards the repurposing of marine bioactive compounds to target SARS-CoV-2. Arab. J. Chem. 14, 103092. https:\/\/doi.org\/10.1016\/j.arabjc.2021.103092 (2021).","journal-title":"Arab. J. Chem."},{"key":"27954_CR17","doi-asserted-by":"publisher","first-page":"27","DOI":"10.1016\/j.antiviral.2015.09.003","volume":"123","author":"D Chen","year":"2015","unstructured":"Chen, D. et al. Harmine blocks herpes simplex virus infection through downregulating cellular NF-kappaB and MAPK pathways induced by oxidative stress. Antivir. Res. 123, 27\u201338. https:\/\/doi.org\/10.1016\/j.antiviral.2015.09.003 (2015).","journal-title":"Antivir. Res."},{"key":"27954_CR18","doi-asserted-by":"publisher","first-page":"26","DOI":"10.1016\/j.antiviral.2016.08.018","volume":"134","author":"VM Quintana","year":"2016","unstructured":"Quintana, V. M. et al. Antiviral activity of natural and synthetic beta-carbolines against dengue virus. Antivir. Res. 134, 26\u201333. https:\/\/doi.org\/10.1016\/j.antiviral.2016.08.018 (2016).","journal-title":"Antivir. Res."},{"key":"27954_CR19","doi-asserted-by":"publisher","first-page":"111","DOI":"10.1016\/j.intimp.2018.04.050","volume":"60","author":"D Chen","year":"2018","unstructured":"Chen, D. et al. Harmine, a small molecule derived from natural sources, inhibits enterovirus 71 replication by targeting NF-\u03baB pathway. Int. Immunopharmacol. 60, 111\u2013120 (2018).","journal-title":"Int. Immunopharmacol."},{"key":"27954_CR20","doi-asserted-by":"publisher","first-page":"1995","DOI":"10.3892\/ijo.2019.4777","volume":"54","author":"Y Ding","year":"2019","unstructured":"Ding, Y. et al. Harmine induces anticancer activity in breast cancer cells via targeting TAZ. Int. J. Oncol. 54, 1995\u20132004. https:\/\/doi.org\/10.3892\/ijo.2019.4777 (2019).","journal-title":"Int. J. Oncol."},{"key":"27954_CR21","first-page":"1573","volume":"6","author":"J Asgarpanah","year":"2012","unstructured":"Asgarpanah, J. & Ramezanloo, F. Chemistry, pharmacology and medicinal properties of Peganum harmala L.. Afr. J. Pharm. Pharmacol 6, 1573\u20131580 (2012).","journal-title":"Afr. J. Pharm. Pharmacol"},{"key":"27954_CR22","doi-asserted-by":"publisher","first-page":"1046","DOI":"10.3390\/v12091046","volume":"12","author":"A Mostafa","year":"2020","unstructured":"Mostafa, A. et al. PA from a recent H9N2 (G1-Like) avian influenza a virus (AIV) strain carrying lysine 367 confers altered replication efficiency and pathogenicity to contemporaneous H5N1 in mammalian systems. Viruses 12, 1046. https:\/\/doi.org\/10.3390\/v12091046 (2020).","journal-title":"Viruses"},{"key":"27954_CR23","doi-asserted-by":"publisher","first-page":"526","DOI":"10.3389\/fmicb.2018.00526","volume":"9","author":"H Petersen","year":"2018","unstructured":"Petersen, H. et al. NS segment of a 1918 influenza a virus-descendent enhances replication of H1N1pdm09 and virus-induced cellular immune response in mammalian and avian systems. Front. Microbiol. 9, 526 (2018).","journal-title":"Front. Microbiol."},{"key":"27954_CR24","doi-asserted-by":"publisher","first-page":"283","DOI":"10.1016\/j.fct.2008.10.027","volume":"47","author":"PS Rao","year":"2009","unstructured":"Rao, P. S., Ramanadham, M. & Prasad, M. N. Anti-proliferative and cytotoxic effects of strychnos nux-vomica root extract on human multiple myeloma cell line\u2014RPMI 8226. Food Chem. Toxicol. 47, 283\u2013288. https:\/\/doi.org\/10.1016\/j.fct.2008.10.027 (2009).","journal-title":"Food Chem. Toxicol."},{"key":"27954_CR25","doi-asserted-by":"publisher","first-page":"638","DOI":"10.1007\/s10517-012-1786-5","volume":"153","author":"EG Skurikhin","year":"2012","unstructured":"Skurikhin, E. G. et al. Mechanisms of the anti-inflammatory and antifibrotic activity of a sympatholytic agent during toxic pulmonary fibrosis. Bull. Exp. Biol. Med. 153, 638\u2013643. https:\/\/doi.org\/10.1007\/s10517-012-1786-5 (2012).","journal-title":"Bull. Exp. Biol. Med."},{"key":"27954_CR26","doi-asserted-by":"publisher","first-page":"CD007655","DOI":"10.1002\/14651858.CD007655.pub3","volume":"12","author":"SD Shamon","year":"2016","unstructured":"Shamon, S. D. & Perez, M. I. Blood pressure-lowering efficacy of reserpine for primary hypertension. Cochrane Database Syst. Rev. 12, CD007655. https:\/\/doi.org\/10.1002\/14651858.CD007655.pub3 (2016).","journal-title":"Cochrane Database Syst. Rev."},{"key":"27954_CR27","doi-asserted-by":"publisher","first-page":"40","DOI":"10.1007\/s11655-017-2805-1","volume":"24","author":"M Li","year":"2018","unstructured":"Li, M., Li, P., Zhang, M. & Ma, F. Brucine suppresses breast cancer metastasis via inhibiting epithelial mesenchymal transition and matrix metalloproteinases expressions. Chin. J. Integr. Med. 24, 40\u201346. https:\/\/doi.org\/10.1007\/s11655-017-2805-1 (2018).","journal-title":"Chin. J. Integr. Med."},{"key":"27954_CR28","doi-asserted-by":"publisher","first-page":"377","DOI":"10.3389\/fphar.2020.00377","volume":"11","author":"L Lu","year":"2020","unstructured":"Lu, L. et al. Brucine: A review of phytochemistry, pharmacology, and toxicology. Front. Pharmacol. 11, 377. https:\/\/doi.org\/10.3389\/fphar.2020.00377 (2020).","journal-title":"Front. Pharmacol."},{"key":"27954_CR29","doi-asserted-by":"publisher","first-page":"2297","DOI":"10.3390\/molecules26082297","volume":"26","author":"F Omar","year":"2021","unstructured":"Omar, F. et al. Plant-based indole alkaloids: A comprehensive overview from a pharmacological perspective. Molecules 26, 2297. https:\/\/doi.org\/10.3390\/molecules26082297 (2021).","journal-title":"Molecules"},{"key":"27954_CR30","doi-asserted-by":"publisher","first-page":"CD011689","DOI":"10.1002\/14651858.CD011689.pub3","volume":"12","author":"ID Gallos","year":"2018","unstructured":"Gallos, I. D. et al. Uterotonic agents for preventing postpartum haemorrhage: a network meta-analysis. Cochrane Database Syst. Rev. 12, CD011689. https:\/\/doi.org\/10.1002\/14651858.CD011689.pub3 (2018).","journal-title":"Cochrane Database Syst. Rev."},{"key":"27954_CR31","doi-asserted-by":"publisher","first-page":"551","DOI":"10.1016\/j.ntt.2010.04.054","volume":"32","author":"YH Kim","year":"2010","unstructured":"Kim, Y. H. et al. Reduced neuronal proliferation by proconvulsant drugs in the developing zebrafish brain. Neurotoxicol. Teratol. 32, 551\u2013557. https:\/\/doi.org\/10.1016\/j.ntt.2010.04.054 (2010).","journal-title":"Neurotoxicol. Teratol."},{"key":"27954_CR32","doi-asserted-by":"publisher","first-page":"9","DOI":"10.1016\/j.fm.2016.09.011","volume":"62","author":"GM Olmedo","year":"2017","unstructured":"Olmedo, G. M. et al. Antifungal activity of \u03b2-carbolines on Penicillium digitatum and Botrytis cinerea. Food Microbiol. 62, 9\u201314 (2017).","journal-title":"Food Microbiol."},{"key":"27954_CR33","doi-asserted-by":"publisher","first-page":"353","DOI":"10.1016\/j.fct.2011.10.052","volume":"50","author":"MA El Gendy","year":"2012","unstructured":"El Gendy, M. A., Soshilov, A. A., Denison, M. S. & El-Kadi, A. O. Harmaline and harmalol inhibit the carcinogen-activating enzyme CYP1A1 via transcriptional and posttranslational mechanisms. Food Chem. Toxicol. 50, 353\u2013362 (2012).","journal-title":"Food Chem. Toxicol."},{"key":"27954_CR34","doi-asserted-by":"publisher","first-page":"853","DOI":"10.2174\/1389200218666170607100947","volume":"18","author":"H Khan","year":"2017","unstructured":"Khan, H., Patel, S. & Kamal, A. M. Pharmacological and toxicological profile of harmane-\u03b2-carboline alkaloid: Friend or foe. Curr. Drug Metabol. 18, 853\u2013857 (2017).","journal-title":"Curr. Drug Metabol."},{"key":"27954_CR35","doi-asserted-by":"publisher","first-page":"2720","DOI":"10.1080\/14786419.2017.1375914","volume":"32","author":"JF Cavalcanti","year":"2018","unstructured":"Cavalcanti, J. F. et al. Proposed anti-HSV compounds isolated from simira species. Nat. Prod. Res. 32, 2720\u20132723 (2018).","journal-title":"Nat. Prod. Res."},{"key":"27954_CR36","doi-asserted-by":"publisher","first-page":"459","DOI":"10.1016\/j.ijantimicag.2018.06.019","volume":"52","author":"MM Gonzalez","year":"2018","unstructured":"Gonzalez, M. M. et al. \u03b2-Carboline derivatives as novel antivirals for herpes simplex virus. Int. J. Antimicrob. Agents 52, 459\u2013468 (2018).","journal-title":"Int. J. Antimicrob. Agents"},{"key":"27954_CR37","doi-asserted-by":"publisher","first-page":"4810394","DOI":"10.1155\/2018\/4810394","volume":"2018","author":"T Herraiz","year":"2018","unstructured":"Herraiz, T. & Guill\u00e9n, H. Monoamine oxidase\u2014A inhibition and associated antioxidant activity in plant extracts with potential antidepressant actions. BioMed Res. Int. 2018, 4810394 (2018).","journal-title":"BioMed Res. Int."},{"key":"27954_CR38","doi-asserted-by":"publisher","first-page":"21550","DOI":"10.1021\/acsomega.0c02165","volume":"5","author":"S Roy","year":"2020","unstructured":"Roy, S. et al. Discovery of harmaline as a potent inhibitor of sphingosine kinase-1: A chemopreventive role in lung cancer. ACS Omega 5, 21550\u201321560 (2020).","journal-title":"ACS Omega"},{"key":"27954_CR39","doi-asserted-by":"publisher","first-page":"752","DOI":"10.1016\/j.ejmech.2018.11.024","volume":"162","author":"CR Sahoo","year":"2019","unstructured":"Sahoo, C. R., Paidesetty, S. K. & Padhy, R. N. Norharmane as a potential chemical entity for development of anticancer drugs. Eur. J. Med. Chem. 162, 752\u2013764 (2019).","journal-title":"Eur. J. Med. Chem."},{"key":"27954_CR40","doi-asserted-by":"publisher","first-page":"254","DOI":"10.1016\/j.phymed.2017.10.013","volume":"36","author":"J-H Lee","year":"2017","unstructured":"Lee, J.-H., Kim, Y.-G., Shim, S. H. & Lee, J. Antibiofilm activities of norharmane and its derivatives against Escherichia coli O157: H7 and other bacteria. Phytomedicine 36, 254\u2013261 (2017).","journal-title":"Phytomedicine"},{"key":"27954_CR41","doi-asserted-by":"publisher","first-page":"493","DOI":"10.1093\/oxfordjournals.aje.a118408","volume":"27","author":"LJ Reed","year":"1938","unstructured":"Reed, L. J. & Muench, H. A simple method of estimating fifty per cent endpoints. Am. J. Epidemiol. 27, 493\u2013497 (1938).","journal-title":"Am. J. Epidemiol."},{"key":"27954_CR42","doi-asserted-by":"publisher","first-page":"588","DOI":"10.1128\/am.16.4.588-594.1968","volume":"16","author":"CR Gaush","year":"1968","unstructured":"Gaush, C. R. & Smith, T. F. Replication and plaque assay of influenza virus in an established line of canine kidney cells. Appl. Microbiol. 16, 588\u2013594 (1968).","journal-title":"Appl. Microbiol."},{"key":"27954_CR43","doi-asserted-by":"publisher","first-page":"e07962","DOI":"10.1016\/j.heliyon.2021.e07962","volume":"7","author":"A Mahmoud","year":"2021","unstructured":"Mahmoud, A. et al. Telaprevir is a potential drug for repurposing against SARS-CoV-2: Computational and in vitro studies. Heliyon 7, e07962 (2021).","journal-title":"Heliyon"},{"key":"27954_CR44","doi-asserted-by":"publisher","first-page":"443","DOI":"10.3390\/ph13120443","volume":"13","author":"A Mostafa","year":"2020","unstructured":"Mostafa, A. et al. FDA-approved drugs with potent in vitro antiviral activity against severe acute respiratory syndrome coronavirus 2. Pharmaceuticals 13, 443. https:\/\/doi.org\/10.3390\/ph13120443 (2020).","journal-title":"Pharmaceuticals"},{"key":"27954_CR45","doi-asserted-by":"publisher","first-page":"pdb.prot087379","DOI":"10.1101\/pdb.prot087379","volume":"2016","author":"M Feoktistova","year":"2016","unstructured":"Feoktistova, M., Geserick, P. & Leverkus, M. Crystal violet assay for determining viability of cultured cells. Cold Spring Harb. Protoc. 2016, pdb.prot087379. https:\/\/doi.org\/10.1101\/pdb.prot087379 (2016).","journal-title":"Cold Spring Harb. Protoc."},{"key":"27954_CR46","doi-asserted-by":"publisher","first-page":"2935","DOI":"10.1016\/j.bmc.2019.05.024","volume":"27","author":"V Zima","year":"2019","unstructured":"Zima, V. et al. Investigation of flexibility of neuraminidase 150-loop using tamiflu derivatives in influenza A viruses H1N1 and H5N1. Bioorg. Med. Chem. 27, 2935\u20132947. https:\/\/doi.org\/10.1016\/j.bmc.2019.05.024 (2019).","journal-title":"Bioorg. Med. Chem."},{"key":"27954_CR47","doi-asserted-by":"publisher","first-page":"15219","DOI":"10.1021\/jacs.8b06741","volume":"140","author":"JL Thomaston","year":"2018","unstructured":"Thomaston, J. L. et al. Inhibitors of the M2 proton channel engage and disrupt transmembrane networks of hydrogen-bonded waters. J. Am. Chem. Soc. 140, 15219\u201315226. https:\/\/doi.org\/10.1021\/jacs.8b06741 (2018).","journal-title":"J. Am. Chem. Soc."},{"key":"27954_CR48","doi-asserted-by":"publisher","DOI":"10.1021\/acsomega.2c04867","author":"A Hegazy","year":"2022","unstructured":"Hegazy, A. et al. Robust antiviral activity of santonica flower extract (Artemisia cina) against avian and human influenza A viruses: In vitro and chemoinformatic studies. ACS Omega https:\/\/doi.org\/10.1021\/acsomega.2c04867 (2022).","journal-title":"ACS Omega"},{"key":"27954_CR49","doi-asserted-by":"publisher","first-page":"205873842110026","DOI":"10.1177\/20587384211002621","volume":"35","author":"S Kausar","year":"2021","unstructured":"Kausar, S. et al. A review: Mechanism of action of antiviral drugs. Int. J. Immunopathol. Pharmacol. 35, 20587384211002620. https:\/\/doi.org\/10.1177\/20587384211002621 (2021).","journal-title":"Int. J. Immunopathol. Pharmacol."},{"key":"27954_CR50","doi-asserted-by":"publisher","first-page":"2451","DOI":"10.1021\/jm980162u","volume":"41","author":"CU Kim","year":"1998","unstructured":"Kim, C. U. et al. Structure\u2212activity relationship studies of novel carbocyclic influenza neuraminidase inhibitors. J. Med. Chem. 41, 2451\u20132460. https:\/\/doi.org\/10.1021\/jm980162u (1998).","journal-title":"J. Med. Chem."},{"key":"27954_CR51","doi-asserted-by":"publisher","first-page":"980","DOI":"10.1038\/nsb1203-980","volume":"10","author":"H Berman","year":"2003","unstructured":"Berman, H., Henrick, K. & Nakamura, H. Announcing the worldwide protein data bank. Nat. Struct. Biol. 10, 980. https:\/\/doi.org\/10.1038\/nsb1203-980 (2003).","journal-title":"Nat. Struct. Biol."},{"key":"27954_CR52","doi-asserted-by":"publisher","first-page":"163","DOI":"10.1016\/B978-0-08-100098-4.00005-3","volume-title":"A practical guide to rational drug design","author":"S Hongmao","year":"2016","unstructured":"Hongmao, S. In A practical guide to rational drug design (ed. Hongmao, Sun) 163\u2013192 (Woodhead Publishing, 2016)."},{"key":"27954_CR53","doi-asserted-by":"publisher","first-page":"353","DOI":"10.1016\/j.jff.2019.01.031","volume":"54","author":"G Torabian","year":"2019","unstructured":"Torabian, G., Valtchev, P., Adil, Q. & Dehghani, F. Anti-influenza activity of elderberry (Sambucus nigra). J. Funct. Foods 54, 353\u2013360 (2019).","journal-title":"J. Funct. Foods"},{"key":"27954_CR54","doi-asserted-by":"publisher","first-page":"8294","DOI":"10.3390\/ijms21218294","volume":"21","author":"V Ulyanova","year":"2020","unstructured":"Ulyanova, V. et al. Anti-influenza activity of the ribonuclease binase: Cellular targets detected by quantitative proteomics. Int. J. Mol. Sci. 21, 8294 (2020).","journal-title":"Int. J. Mol. Sci."},{"key":"27954_CR55","doi-asserted-by":"publisher","first-page":"87","DOI":"10.1016\/j.tim.2017.12.003","volume":"26","author":"A Mostafa","year":"2018","unstructured":"Mostafa, A. & Pleschka, S. Influenza H3N2 vaccines: Recent challenges. Trends Microbiol. 26, 87\u201389. https:\/\/doi.org\/10.1016\/j.tim.2017.12.003 (2018).","journal-title":"Trends Microbiol."},{"key":"27954_CR56","doi-asserted-by":"publisher","first-page":"1505","DOI":"10.1007\/s00705-016-2815-x","volume":"161","author":"A Mostafa","year":"2016","unstructured":"Mostafa, A. et al. Phylogenetic analysis of human influenza A\/H3N2 viruses isolated in 2015 in Germany indicates significant genetic divergence from vaccine strains. Adv. Virol. 161, 1505\u20131515. https:\/\/doi.org\/10.1007\/s00705-016-2815-x (2016).","journal-title":"Adv. Virol."},{"key":"27954_CR57","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1038\/s41598-016-0028-x","volume":"7","author":"S-S Liu","year":"2017","unstructured":"Liu, S.-S. et al. Susceptibility of influenza A (H1N1)\/pdm2009, seasonal A (H3N2) and B viruses to Oseltamivir in Guangdong, China between 2009 and 2014. Sci. Rep. 7, 1\u201311 (2017).","journal-title":"Sci. Rep."},{"key":"27954_CR58","doi-asserted-by":"publisher","first-page":"2297","DOI":"10.3390\/molecules26082297","volume":"26","author":"F Omar","year":"2021","unstructured":"Omar, F. et al. Plant-based indole alkaloids: A comprehensive overview from a pharmacological perspective. Molecules 26, 2297 (2021).","journal-title":"Molecules"},{"key":"27954_CR59","doi-asserted-by":"publisher","first-page":"42","DOI":"10.1016\/j.micpath.2017.06.014","volume":"110","author":"M-T Moradi","year":"2017","unstructured":"Moradi, M.-T., Karimi, A., Rafieian-Kopaei, M. & Fotouhi, F. In vitro antiviral effects of Peganum harmala seed extract and its total alkaloids against influenza virus. Microb. Pathog. 110, 42\u201349 (2017).","journal-title":"Microb. Pathog."},{"key":"27954_CR60","first-page":"519","volume":"7","author":"MT Moradi","year":"2017","unstructured":"Moradi, M. T., Karimi, A., Fotouhi, F., Kheiri, S. & Torabi, A. In vitro and in vivo effects of Peganum harmala L. seeds extract against influenza A virus. Avicenna J. Phytomed. 7, 519\u2013530 (2017).","journal-title":"Avicenna J. Phytomed."},{"key":"27954_CR61","volume-title":"StatPearls","author":"J Otter","year":"2022","unstructured":"Otter, J. & D\u2019Orazio, J. L. StatPearls (StatPearls Publishing, 2022)."},{"key":"27954_CR62","doi-asserted-by":"publisher","first-page":"199","DOI":"10.4103\/0973-7847.120524","volume":"7","author":"M Moloudizargari","year":"2013","unstructured":"Moloudizargari, M., Mikaili, P., Aghajanshakeri, S., Asghari, M. H. & Shayegh, J. Pharmacological and therapeutic effects of Peganum harmala and its main alkaloids. Pharmacogn. Rev. 7, 199\u2013212. https:\/\/doi.org\/10.4103\/0973-7847.120524 (2013).","journal-title":"Pharmacogn. Rev."}],"container-title":["Scientific Reports"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/www.nature.com\/articles\/s41598-023-27954-0.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/www.nature.com\/articles\/s41598-023-27954-0","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/www.nature.com\/articles\/s41598-023-27954-0.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2023,1,28]],"date-time":"2023-01-28T06:40:42Z","timestamp":1674888042000},"score":1,"resource":{"primary":{"URL":"https:\/\/www.nature.com\/articles\/s41598-023-27954-0"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2023,1,28]]},"references-count":62,"journal-issue":{"issue":"1","published-online":{"date-parts":[[2023,12]]}},"alternative-id":["27954"],"URL":"https:\/\/doi.org\/10.1038\/s41598-023-27954-0","relation":{},"ISSN":["2045-2322"],"issn-type":[{"value":"2045-2322","type":"electronic"}],"subject":[],"published":{"date-parts":[[2023,1,28]]},"assertion":[{"value":"13 September 2022","order":1,"name":"received","label":"Received","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"10 January 2023","order":2,"name":"accepted","label":"Accepted","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"28 January 2023","order":3,"name":"first_online","label":"First Online","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"The authors declare no competing interests.","order":1,"name":"Ethics","group":{"name":"EthicsHeading","label":"Competing interests"}}],"article-number":"1612"}}